Cargando…
Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders
Telomeres are nucleoprotein complexes present at the ends of chromosome to maintain its integrity. Telomere length is maintained by an enzyme called "telomerase". Thus, telomerase activity and telomere length are crucial for the initiation of cancer and tumors survival. Also, oxidative str...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Babol University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256828/ https://www.ncbi.nlm.nih.gov/pubmed/34268254 http://dx.doi.org/10.22088/IJMCM.BUMS.10.1.56 |
_version_ | 1783718175627542528 |
---|---|
author | Farid Aql, Maha Mohamed Bahget, Seham Abd-El Ghafour Kholoussi, Naglaa Abdel-Salam, Ghada Mohamed El Hossiny Abdel Raouf, Haiam Mohamed Eid, Maha Esmail, Rania El-Bialy |
author_facet | Farid Aql, Maha Mohamed Bahget, Seham Abd-El Ghafour Kholoussi, Naglaa Abdel-Salam, Ghada Mohamed El Hossiny Abdel Raouf, Haiam Mohamed Eid, Maha Esmail, Rania El-Bialy |
author_sort | Farid Aql, Maha Mohamed |
collection | PubMed |
description | Telomeres are nucleoprotein complexes present at the ends of chromosome to maintain its integrity. Telomere length is maintained by an enzyme called "telomerase". Thus, telomerase activity and telomere length are crucial for the initiation of cancer and tumors survival. Also, oxidative stress will cause DNA, protein, and/or lipid damage, which end with changes in chromosome instability, genetic mutation, and may affect cell growth and lead to cancer. Some genetic diseases such as chromosomal instability syndrome, overgrowth syndrome, and neurofibromatosis make the patients at higher risk for developing different types of cancers. Therefore, we aimed to estimate telomerase activity and oxidative stress in these patients. Blood samples were collected from 31 patients (10 with neurofibromatosis, 11 with chromosomal breakage, and 10 with overgrowth syndrome) and 12 healthy subjects. Blood hTERT mRNA was detected by real time quantitative reverse-transcription PCR (RT-qPCR). All patients were subjected to chromosomal examination and chromosome breakage study using diepoxybutane method. Moreover, serum glutathione (GSH), glutathione-s-transferase (GST) activity and nitric oxide (NO) levels were measured among the control and patients groups. Receiver operating characteristic (ROC) curve was drawn to evaluate the efficiency of telomerase activity as a biomarker for the prediction of cancer occurrence. The relative telomerase activity in neurofibromatosis patients was significantly higher than controls (P = 0.014), while it was non-significantly higher in chromosomal breakage and overgrowth patients (P = 0.424 and 0.129, respectively). NO levels in neurofibromatosis, chromosomal breakage and overgrowth patients significantly increased with respect to control (P = 0.021, 0.002, 0.050, respectively). GSH levels were non-significantly lower in neurofibromatosis and chromosomal breakage patients in comparison with the control group, while it remained unchanged in overgrowth patients. The GST activity was significantly upregulated in neurofibromatosis, chromosomal breakage and overgrowth groups in comparison with the control group (P = 0.001, 0.009, and 0.025, respectively). Chromosomal examination revealed normal karyotype in all four chromosomal breakage patients with positive diepoxybutane test. The results of the present study revealed altered telomerase activity and oxidative stress in the studied genetic disorders. More research studies with a larger number of patients are required to confirm whether this alteration is related to cancer occurrence risk or not. |
format | Online Article Text |
id | pubmed-8256828 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Babol University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-82568282021-07-14 Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders Farid Aql, Maha Mohamed Bahget, Seham Abd-El Ghafour Kholoussi, Naglaa Abdel-Salam, Ghada Mohamed El Hossiny Abdel Raouf, Haiam Mohamed Eid, Maha Esmail, Rania El-Bialy Int J Mol Cell Med Original Article Telomeres are nucleoprotein complexes present at the ends of chromosome to maintain its integrity. Telomere length is maintained by an enzyme called "telomerase". Thus, telomerase activity and telomere length are crucial for the initiation of cancer and tumors survival. Also, oxidative stress will cause DNA, protein, and/or lipid damage, which end with changes in chromosome instability, genetic mutation, and may affect cell growth and lead to cancer. Some genetic diseases such as chromosomal instability syndrome, overgrowth syndrome, and neurofibromatosis make the patients at higher risk for developing different types of cancers. Therefore, we aimed to estimate telomerase activity and oxidative stress in these patients. Blood samples were collected from 31 patients (10 with neurofibromatosis, 11 with chromosomal breakage, and 10 with overgrowth syndrome) and 12 healthy subjects. Blood hTERT mRNA was detected by real time quantitative reverse-transcription PCR (RT-qPCR). All patients were subjected to chromosomal examination and chromosome breakage study using diepoxybutane method. Moreover, serum glutathione (GSH), glutathione-s-transferase (GST) activity and nitric oxide (NO) levels were measured among the control and patients groups. Receiver operating characteristic (ROC) curve was drawn to evaluate the efficiency of telomerase activity as a biomarker for the prediction of cancer occurrence. The relative telomerase activity in neurofibromatosis patients was significantly higher than controls (P = 0.014), while it was non-significantly higher in chromosomal breakage and overgrowth patients (P = 0.424 and 0.129, respectively). NO levels in neurofibromatosis, chromosomal breakage and overgrowth patients significantly increased with respect to control (P = 0.021, 0.002, 0.050, respectively). GSH levels were non-significantly lower in neurofibromatosis and chromosomal breakage patients in comparison with the control group, while it remained unchanged in overgrowth patients. The GST activity was significantly upregulated in neurofibromatosis, chromosomal breakage and overgrowth groups in comparison with the control group (P = 0.001, 0.009, and 0.025, respectively). Chromosomal examination revealed normal karyotype in all four chromosomal breakage patients with positive diepoxybutane test. The results of the present study revealed altered telomerase activity and oxidative stress in the studied genetic disorders. More research studies with a larger number of patients are required to confirm whether this alteration is related to cancer occurrence risk or not. Babol University of Medical Sciences 2021 2021-05-22 /pmc/articles/PMC8256828/ /pubmed/34268254 http://dx.doi.org/10.22088/IJMCM.BUMS.10.1.56 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Farid Aql, Maha Mohamed Bahget, Seham Abd-El Ghafour Kholoussi, Naglaa Abdel-Salam, Ghada Mohamed El Hossiny Abdel Raouf, Haiam Mohamed Eid, Maha Esmail, Rania El-Bialy Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders |
title | Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders |
title_full | Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders |
title_fullStr | Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders |
title_full_unstemmed | Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders |
title_short | Telomerase Dysfunction in the Tumorigenesis of Genetic Disorders |
title_sort | telomerase dysfunction in the tumorigenesis of genetic disorders |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256828/ https://www.ncbi.nlm.nih.gov/pubmed/34268254 http://dx.doi.org/10.22088/IJMCM.BUMS.10.1.56 |
work_keys_str_mv | AT faridaqlmahamohamed telomerasedysfunctioninthetumorigenesisofgeneticdisorders AT bahgetsehamabdelghafour telomerasedysfunctioninthetumorigenesisofgeneticdisorders AT kholoussinaglaa telomerasedysfunctioninthetumorigenesisofgeneticdisorders AT abdelsalamghadamohamedelhossiny telomerasedysfunctioninthetumorigenesisofgeneticdisorders AT abdelraoufhaiam telomerasedysfunctioninthetumorigenesisofgeneticdisorders AT mohamedeidmaha telomerasedysfunctioninthetumorigenesisofgeneticdisorders AT esmailraniaelbialy telomerasedysfunctioninthetumorigenesisofgeneticdisorders |